
Johnsoncab Electricals IPO Details
Last Updated on October 30, 2026 Johnsoncab Electricals Ltd. IPO Incorporated on November 12, 2020, Johnsoncab Electricals Limited originated as a partnership firm named M/s. Johnson Cables in February 2012.
Founded in 2001 by Mr. Dhirajlal Kotadia, Sahajanand Medical Technologies Ltd. is a medical device company focused on Class III and Class C/D devices, primarily in the fields of vascular and structural heart intervention. The company was the first globally to receive CE certification for a drug-eluting stent (DES) with a biodegradable polymer—Infinnium.
The product portfolio spans three key categories:
Sahajanand operates two R&D centers—one in India and one in Thailand—supported by a team of 102 professionals, including biomedical engineers and clinical research specialists. The company has built a robust intellectual property base, with 102 patents granted globally and 71 pending patent applications, along with five design registrations in India.
Key products such as Supraflex Cruz (DES), Hydra (TAVI), and Cocoon (Occluders) are backed by 72 clinical studies, and are widely accepted in over 76 countries across Europe, Asia, and other regions. The global distribution strategy includes direct operations in key European markets (Germany, Spain, France, UK), hybrid models in India (serving hospitals like Narayana Hrudayalaya Limited), and distributor-led entry in markets such as Italy.
International market adoption is reinforced by endorsements from key opinion leaders (KOLs), successful government tenders, and partnerships with major Group Purchasing Organizations (GPOs) in Europe.
The company follows a “House of Brand” strategy, developing and commercializing clinically differentiated products under recognized brand names like Supraflex Cruz, Hydra, and Cocoon.
As of March 31, 2025, Sahajanand Medical Technologies employed 1,458 full-time staff, 24 consultants, and 818 contract-based personnel across its operations.
Sahajanand Medical Technologies Ltd.’s revenue increased by 18% and profit after tax (PAT) rose by 175% between the financial year ending with March 31, 2026 and March 31, 2025.
| Period Ended | 30 Jun 2026 | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|---|
| Assets | 1,309.00 | 1,276.43 | 1,094.90 | 970.58 |
| Total Income | 354.33 | 1,218.73 | 1,035.96 | 908.59 |
| Profit After Tax | 15.09 | 69.08 | 25.15 | -7.35 |
| EBITDA | 48.58 | 170.66 | 128.02 | 110.05 |
| NET Worth | 631.72 | 616.05 | 545.23 | 526.30 |
| Reserves and Surplus | 706.86 | 692.48 | 580.71 | 556.57 |
| Total Borrowing | 320.63 | 269.53 | 224.96 | 175.27 |
| Amount in ₹ Crore | ||||
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Rays of Belief Ltd. | Mainboard | ₹125.00 Cr | ₹239 | 75.63 | ₹228.34 | -4.46% | ₹215.56 |
| Manipal Health Enterprises Ltd. | Mainboard | ₹9,275.22 Cr | ₹590 | 75.93 | ₹666.95 | +13.04% | ₹701.30 |
| Gujarat Kidney & Super Speciality Ltd. | Mainboard | ₹250.80 Cr | ₹114 | 61.62 | ₹104.54 | -8.30% | ₹184.09 |
The Sahajanand Medical Technologies Ltd. IPO is a 100% Offer for Sale (OFS), so the company will not receive any funding and the entire IPO proceeds will go to the selling shareholders.
| KPI | Jun 30, 2026 | Mar 31, 2026 |
|---|---|---|
| ROE | 2.07% | 10.35% |
| ROCE | 3.16% | 11.57% |
| Debt/Equity | 0.33 | 0.27 |
| RoNW | 2.31% | 10.60% |
| PAT Margin | 4.29% | 5.71% |
| EBITDA Margin | 13.81% | 14.10% |
| NAV | 64.35 | 62.76 |
| Valuation Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 6.80 | 5.94 |
| IPO Date | 15 to 19 Oct, 2026 |
| Listing Date | Fri, Oct 23, 2026T |
| Face Value | ₹1 per share |
| Price Band | |
| Sale Type | OFS only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 2,76,44,231 shares (agg. up to ₹[.] Cr) |
| Offer for Sale | 2,76,44,231 shares of ₹1 (agg. up to ₹[.] Cr) |
| Share Holding Pre Issue | 10,16,46,778 shares |
| Share Holding Post Issue | 10,16,46,778 shares |
The promoters of the company are Bhargav Dhirajlal Kotadia, Dhirajlal Vallabhbhai Kotadia, Priyanka Dhirajlal Cohen and Shree Hari Trust.
| Share Holding Pre Issue | 35.51% |
| Share Holding Post Issue | 40.82% |
As per our analysis and Based on the information we have, this is the output.
Allah knows best.
If you find this result mistaken or questionable, let us know via email at info (@) halalstock.in
The IPO dashboard offers insights on the Latest Current & Upcoming IPOs in BSE & NSE. It also evaluates IPOs for Shariah compliance, ensuring alignment with Islamic principles for ethical investment choices.

Last Updated on October 30, 2026 Johnsoncab Electricals Ltd. IPO Incorporated on November 12, 2020, Johnsoncab Electricals Limited originated as a partnership firm named M/s. Johnson Cables in February 2012.

Last Updated on October 30, 2026 HGS India Ltd. IPO HGS (India) Limited (HGSI), incorporated in February 1986, manufactures geophones, geophone strings, seismic cables, connectors and accessories used in seismic

Last Updated on October 30, 2026 Vectras Enprocon Ltd. IPO Vectras Enprocon Ltd. is a Gujarat-based Engineering, Procurement and Construction (EPC) company operating in the midstream and downstream segments of
You can contribute as little as
100, 200, 500 & so…
every bit counts.